IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
NICERIUM (ce re bral/pe riph eral vasotherapeutic)
AMLOHEXAL (cal cium an tag o nist plain)
SIMVAHEXAL (cho les terol/triglyceride reg u lat ing
prep a ra tion)
ACC 200 (ex pec to rant)
DICLAC (antirheumatic top i cal; antirheumatic
non-steroidal)
Ther a peu tic Range:
ce re bral/pe riph eral vasotherapeutics 30%
cal cium an tag o nists 19%
cough and cold prep a ra tions 14%
lipid-reg u lat ing/antiatheroma prep a ra tions
11%
anti rheu ma tics top i cal 8%
Lead ing Dose Forms:
cap sules 39%
coated tab lets 30%
tab lets 15%
gels/sols 8%
liq uids 4%
LEK
Full Name: Lek PharmaTech S.R.L., Targu-Mures
Street Ad dress: Str. Livezeni nr. 7A, 540472
Targu-Mures
Tel: +40 26 520 81 23
Fax: +40 26 520 47 67
De scrip tion: Rep re sen ta tive of fice.
Con tacts (Pharm): Chair man: Tomislav Cuk;
Gen eral Con tact: Tomislav Cuk
Phar ma ceu ti cal Sales: US$ 45-50 mil lion
Prod ucts (% of Sales by Lead ing 5): 70-75%
Ther a peu tic Classes (% of Sales by Lead ing
5): 85-90%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
KETONAL (antirheumatic non-steroidal;
antirheumatic top i cal)
AMOKSIKLAV 2 (pen i cil lin broad spec trum)
AXYCEF (cephalosporin)
LEKOKLAR (macrolide/sim i lar type)
AZITROMICINA (macrolide/sim i lar type)
Ther a peu tic Range:
antibacterials sys temic 48%
anti rheu ma tics sys temic 29%
anti rheu ma tics top i cal 4%
an ti his ta mines sys temic 4%
renin-an gio ten sin sys tem agents 4%
Lead ing Dose Forms:
tab lets 39%
coated tab lets 27%
liq uids 11%
cap sules 10%
gels/sols 4%
NOVARTIS
Full Name: Novartis Pharma Ser vices AG, Rep re -
sen ta tive Of fice
Street Ad dress: Bu cha rest Busi ness Park, en -
trance B, parter (ground floor), 1A, Sos. Bucuresti
- Ploiesti, 013681 Bu cha rest
Tel: +40 21 312 99 01
Fax: +40 21 312 99 07
Phar ma ceu ti cal Sales: US$ 85-90 mil lion
Prod ucts (% of Sales by Lead ing 5): 65-70%
Ther a peu tic Classes (% of Sales by Lead ing
5): 70-75%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
GLIVEC (antineoplastic other)
EXELON (anti-Alz hei mer prod uct)
ZOMETA (bone cal cium reg u la tor)
STALEVO (antiparkinson drug)
FEMARA (cytostatic hor mone an tag o nist)
Ther a peu tic Range:
antineoplastics 31%
CNS drugs other 14%
antiparkinson drugs 11%
musculoskeletal drugs other 10%
renin-an gio ten sin sys tem agents 8%
Lead ing Dose Forms:
cap sules 50%
coated tab lets 27%
in fu sions 10%
tab lets 8%
am poules 3%
NOVARTIS CON SUMER HEALTH
Full Name: Novartis Con sumer Health Ser vices
SA, Rep re sen ta tive Of fice Ro ma nia
Street Ad dress: 133-137 Calea Floreasca, 1st
floor, sec tor 1, Bu cha rest
Tel: +40 21 231 63 44
Fax: +40 21 231 63 43
PHARMATECH
Full Name: Lek Pharmatech srl.
Street Ad dress: Str. Argesului 25, 4300 Tirgu
Mures
Tel: +40 26 521 52 97
© 2009 IMS Health In cor po rated or its af fil i ates Page 200